rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MDT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Medtronic (MDT) Declines More Than Market: Some Information for Investors

      Medtronic (MDT) closed the most recent trading day at $100.72, moving 1.56% from the previous trading session.

      5h agoYahoo FinanceMDT
      Medtronic PLC stock outperforms competitors despite losses on the day
      5h agoMarketWatchMDT
      Medtronic Expands US Robotic Surgery Footprint With New FDA General Surgery Approval
      Nov 17BenzingaMDT
      Medtronic’s Hugo robot gets expanded FDA clearance in general surgery
      Nov 17Yahoo FinanceMDT
      Medtronic stock may move 3.2% on Nov. 24 earnings report
      Nov 17Investing.comMDT
      Medtronic Stock: FDA Clearance Creates Bigger Playing Field for Robot

      Regulatory approval expands the addressable market for Medtronic’s robot to millions of more surgeries.

      Nov 17Barron'sMDT
      Medtronic stock gets $110 target at TD Cowen on FDA clearance
      Nov 17Investing.comMDT
      Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system – Company Announcement - FT.com
      Nov 17Financial TimesMDT
      Piper Sandler upgrades Medtronic stock rating on growth outlook
      Nov 17Investing.comMDT
      Nvidia board needs 'some heavyweights,' ex-Medtronic CEO Bill George says
      Nov 16Yahoo FinanceNVDAMDT
      Medtronic Targets Stroke Prevention Technologies in $380 Million Contego Deal
      Nov 16BenzingaMDT
      Medtronic to acquire Contego Medical for $380 million
      Nov 16Investing.comMDT
      Medtronic PLC stock outperforms competitors on strong trading day
      Nov 13MarketWatchMDT
      Medtronic Kept Growing When All Eyes Were On AI, Time To Give This Growth Justice (MDT)

      Medtronic expands its heart-rhythm business with Affera and PulseSelect, driving material revenue growth. Find out why MDT stock is a buy.

      Nov 12Seeking AlphaMDT
      What Is Medtronic (MDT) Facing After Two Class II Cardiac Device Recalls?
      Nov 11Yahoo FinanceMDT
      Medtronic (MDT) Dips More Than Broader Market: What You Should Know
      Nov 10Yahoo FinanceMDT
      Medtronic PLC stock underperforms Tuesday when compared to competitors
      Nov 10MarketWatchMDT
      US judge to slash $88 million hernia mesh jury award against Medtronic
      Nov 10ReutersMDT
      Can Medtronic (MDT) Still Justify Its Price On Cash Flow?
      Nov 7Yahoo FinanceMDT
      Medtronic (MDT) Reports SPYRAL AFFIRM Results, Is It Still 9% Undervalued?
      Nov 6Yahoo FinanceMDT
      Is Blood Pressure Trial Success Altering The Investment Case For Medtronic (MDT)?

      Medtronic reported that its Symplicity Spyral renal denervation system met the primary endpoint in the SPYRAL AFFIRM post approval study, with statistically significant blood pressure reductions at six months across office, home, and 24 hour monitoring, no increase in antihypertensive medications, and a 2.1% composite safety event rate. The FDA approved expanded labeling for the Symplicity Spyral catheter to include additional clinical data in patients with isolated systolic hypertension,...

      Nov 6Yahoo FinanceMDT
      Medtronic (MDT) Wins FDA Label Expansion After Real World Symplicity Spyral Results

      Medtronic (NYSE:MDT) reported that its Symplicity Spyral Renal Denervation system cut blood pressure meaningfully in a large real world study. The new data supported an FDA label update that widens use of Symplicity Spyral for hypertension, chronic kidney disease, and type 2 diabetes. The labeling change broadens the treated patient pool for renal denervation procedures within Medtronic's cardiovascular portfolio. The FDA label expansion for Symplicity Spyral only captures part of what is...

      Nov 6Yahoo FinanceMDT
      Medtronic Stock: Analyst Estimates & Ratings
      Nov 6BarchartMDT
      Medtronic to announce financial results for its second quarter of fiscal year 2027
      Nov 4Yahoo FinanceMDT
      Medtronic and Michael J. Fox Foundation Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
      Nov 4Yahoo FinanceMDT
      ETFs Are Net Sellers of Medtronic (MDT) on Friday

      ETFs sold $110.6 million of Medtronic on Friday, with 35 funds buying and 15 selling.

      Nov 3Yahoo FinanceNOBLMDT
      Medtronic (MDT) Ascends While Market Falls: Some Facts to Note
      Nov 2Yahoo FinanceMDT
      Medtronic (MDT) Posted Positive Real World Ablation Data
      Nov 1Yahoo FinanceMDT
      Bank of America Securities Remains a Buy on Medtronic (MDT)

      Detailed price information for Medtronic Inc (MDT-N) from The Globe and Mail including charting and trades.

      Oct 31The Globe and MailMDT
      Medtronic’s October Volume Was an Exchange Offer, Not Distribution — $105 Is Next
      Oct 30Investing.comMDT
      Why the Market Dipped But Medtronic (MDT) Gained Today
      Oct 29Yahoo FinanceMDT
      What Have Medtronic Stock Holders Really Earned?
      Oct 29Yahoo FinanceMDT
      Should Steris Stock Holders Look At Medtronic Instead?
      Oct 29Yahoo FinanceMDTSTE
      Medtronic Spark Scholarship Applications Now Open for Students Pursuing Careers in Healthcare Technology
      Oct 28Yahoo FinanceMDT
      Medtronic: Broader Growth, Attractive Valuation (NYSE:MDT)
      Oct 28Seeking AlphaMDT
      Medtronic's Q2 2027 Earnings: What to Expect
      Oct 28BarchartMDT
      ETFs Bought $18.0 Million of Medtronic (MDT) on Oct. 26
      Oct 28Yahoo FinanceMDT
      Medtronic (MDT) Stock Could Be A Bargain On Cash Flow

      Medtronic has delivered a solid 51.6% share price gain over the past three years, while rolling out new cardiac devices and digital tools that could reshape how it earns and collects cash. With the stock around US$95.41, the open question is whether that price tag lines up with what the company’s cash flows can reasonably support. The 51.6% return over three years puts real weight on the issue of whether Medtronic’s current valuation can still be explained by its underlying cash...

      Oct 24Yahoo FinanceMDT
      Medtronic reports real-world findings for cardiac ablation systems
      Oct 23Yahoo FinanceMDT
      Should CE Mark Pacemakers Require Action From Medtronic Stock Investors?
      Oct 21Yahoo FinanceMDT
      Medtronic (MDT) Shares Moved, So What Is Driving Attention Now?
      Oct 21Yahoo FinanceMDT
      Medtronic PLC stock underperforms Tuesday when compared to competitors despite daily gains
      Oct 20MarketWatchMDT
      Medtronic’s next-gen pacemaker portfolio secures CE mark
      Oct 20Yahoo FinanceMDT
      Medtronic (MDT) Sees $94.9 Million in Net ETF Selling on Oct. 16
      Oct 20Yahoo FinanceMDT
      Medtronic (MDT) Stock Dips While Market Gains: Key Facts
      Oct 19Yahoo FinanceMDT
      Medtronic PLC stock underperforms Monday when compared to competitors
      Oct 19MarketWatchMDT
      ETFs Are Buying Medtronic (MDT) on Thursday
      Oct 19Yahoo FinanceMDT
      How Many Shares Would It Take to Earn $1,000 a Year From This Future Dividend King?
      Oct 17Yahoo FinanceMDT
      Why Is Medtronic (MDT) In The Spotlight After TIME Named Two Devices Best Inventions?
      Oct 17Yahoo FinanceMDT
      Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
      Oct 16Yahoo FinanceMDT

      This is the newest page. Registered accounts read further back.